Intranasal peptide contraception by inhibition of ovulation with the gonadotropin-releasing hormone superagonist nafarelin: six months' clinical results.

Source:http://linkedlifedata.com/resource/pubmed/id/2938984

Download in:

View as

General Info

PMID
2938984